Korea Exchange will review whether to delist biotech company SillaJen Inc. due to the indictment of embezzlement and breach of trust charges against its officials.
Company executives were suspected of avoiding massive losses by selling large amounts of stocks ahead of its regulatory filing in August 2019, using inside information that its key product Pexa-Vec failed clinical tests.
Prosecutors also suspect that former Sillajen CEO Moon Eun-sang acquired a stake in the company without any capital by taking over bonds with warrants.
Moon resigned last week as Sillajen CEO after a warrant of arrest was issued against him by the Seoul Southern District Court for using undisclosed information to sell SillaJen stocks and committing other irregularities.
The resignation was also perceived as a means to help SillaJen avoid a delisting.
Top managers’ alleged embezzlement can be a basis for a company to lose eligibility for listing on the stock market.
KOSDAQ has suspended trading of SillaJen stocks since May 4.


Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 



